Weight-loss injections have become increasingly familiar, and many patients are now well aware that treatments containing semaglutide or tirzepatide can cause digestive problems such as nausea, constipation and diarrhoea.
But some potential side effects are considerably more unusual.
People using weight-management injections may experience symptoms ranging from skin that feels painfully sunburnt despite having no visible rash to foul-smelling belches commonly described as “rotten egg” or “sulphur” burps.
Sobia Qasim, pharmacist at UK online pharmacy Curely, explains:
“Most people taking weight-loss injections expect some digestive symptoms, particularly when they begin treatment or increase their dose.
What they may not expect is for their clothes to hurt against their skin or for their burps to suddenly smell like rotten eggs. These symptoms can sound unusual, but there are emerging medical reports and plausible digestive explanations behind them.”
Why Clothes and Bedding May Suddenly Hurt
Among the more surprising potential reactions is a condition called allodynia, where something that would not normally cause pain – such as clothing touching the body – becomes painful.
It can form part of a broader reaction known as dysaesthesia, encompassing altered sensations including burning, tingling, tenderness and increased skin sensitivity.
Some patients have compared the feeling to sunburn, despite there being no visible redness, irritation or rash.
Sobia says:
“Allodynia can make completely ordinary sensations uncomfortable. Clothes rubbing against the body, a bedsheet touching the skin or even a gentle hand may produce pain or a burning sensation.
The absence of a rash can make the symptom particularly confusing. People may initially blame their washing detergent, skincare products or sun exposure because there is nothing visibly wrong with the skin.”
Patients Have Reported Severe Pain
A 2026 case series documented allodynia in two patients using tirzepatide (Mounjaro) for weight management.
One experienced a sunburn-like sensation across the arms and legs on the day of their weekly injection. It lasted for around a day, although it did not occur after every dose.
A second patient developed severe allodynia affecting the whole body after taking tirzepatide. Clothing and bedding made the symptoms worse, with the pain rated at eight out of 10. Symptoms gradually subsided and eventually resolved after treatment was discontinued.
Published reports have also documented allodynia following dose escalation among patients taking semaglutide (Wegovy).
Sobia explains:
“The available evidence remains limited, so we cannot say how frequently this happens or prove that every instance of unexplained skin pain is caused by the medication.
However, several cases show a possible relationship with higher doses or dose escalation. Patients should make a note of when the sensation began, when they last injected their medication and whether their dosage recently changed.”
Wegovy Information Recognises Altered Skin Sensations
UK product information for Wegovy lists dysaesthesia among its potential adverse reactions, covering altered sensations including burning, tingling, sensitive skin, heightened sensitivity and allodynia.
Related events were reported by 2.1% of patients receiving Wegovy injections, compared with 1.2% receiving a placebo. Most were described as mild to moderate, with the majority of affected patients recovering while continuing treatment.
It has not yet been established precisely why such a reaction might occur. One theory is that GLP-1 activity within the nervous system could affect the way pain signals are processed, although this has not been proven.
What Causes ‘Rotten Egg’ Burps?
Another decidedly unpleasant complaint reported by some weight-loss injection users is foul-smelling belching.
Frequently called “sulphur burps”, the distinctive smell or taste is likened to rotten eggs.
GLP-1 medicines slow the rate at which the stomach empties. As food can consequently remain in the digestive system for longer, users may experience fullness, bloating, reflux, belching and nausea.
Sobia explains:
“Sulphur burps get their distinctive rotten-egg smell from hydrogen sulphide gas produced during digestion.
The medication itself does not necessarily create the smell. Slower digestion, the foods eaten and the size of the meal can all contribute. Fizzy drinks may then make belching more frequent by adding additional gas.”
Everyday Foods Could Make Symptoms Worse
There isn’t a universal list of foods that people taking GLP-1 medicines must avoid. Individual tolerance varies considerably, but some foods and drinks could make nausea, reflux, bloating or unpleasant belching worse.
Potential triggers include eggs, red and processed meats, garlic and onions, broccoli, cabbage and cauliflower, fried or high-fat foods, rich sauces, large late-night meals, fizzy drinks, alcohol and protein shakes containing certain sweeteners or sugar alcohols.
Eggs often receive the blame when sulphur burps develop, but Sobia says focusing on a single ingredient may be misleading.
“Eggs naturally contain sulphur compounds, but so do foods including meat, garlic, onions and cruciferous vegetables.
A large, high-fat meal may also take longer to digest. Someone could therefore experience symptoms after a takeaway or rich evening meal even when it did not contain eggs.
Rather than unnecessarily removing nutritious foods, patients can keep a short record of what they ate, their portion size and when symptoms occurred. Patterns are more useful than assuming one ingredient is always responsible.”
Even a Healthier Diet Can Initially Cause Problems
Starting weight-loss treatment can prompt people to overhaul their diets, perhaps suddenly eating considerably more beans, lentils, bran, raw vegetables and protein products.
While many of these foods can form part of a nutritious diet, abruptly increasing fibre intake may aggravate wind, constipation and bloating – particularly when digestion has already slowed.
Sobia says:
“Fibre is important, but going from a relatively low-fibre diet to large salads, bran cereals, beans and lentils overnight can make digestive symptoms considerably worse.
Increase fibre gradually and drink enough fluid. Cooked vegetables, oats, soups and softer fruits may be easier to tolerate than very large portions of raw or tough foods when someone is already feeling bloated or nauseated.”
In rare circumstances, severely delayed stomach emptying can result in undigested material accumulating into a hardened mass known as a bezoar. While this is not considered a routine side effect, persistent vomiting, severe fullness or being unable to tolerate food requires medical assessment.
What to Eat When Side Effects Are Bad
Individual tolerance varies, but smaller, simpler meals can sometimes be easier to manage when nausea or bloating is particularly troublesome.
Options can include toast, crackers, plain rice, oats or simple porridge, soup, cooked vegetables, bananas or stewed fruit and smaller portions of lean protein. Still water can also be consumed gradually.
Sobia advises:
“Portion size may be as important as the food itself. A meal that caused no difficulty before treatment may feel uncomfortable once stomach emptying has slowed.
Eating slowly, stopping when comfortably full and avoiding lying down immediately after eating may help reduce reflux and belching.”
Don’t Change Your Dose Without Medical Advice
Patients experiencing unexplained skin pain or persistent digestive symptoms should contact their prescriber or pharmacist rather than independently skipping, reducing or stopping their medication.
Sobia says:
“These symptoms do not automatically mean the medicine must be stopped. A prescriber will consider their severity, when they began and whether they followed a dose increase.
The dose escalation schedule is there for a reason. Increasing the amount too quickly or using medication without clinical supervision may make side effects harder to manage.”
Warning Signs That Shouldn’t Be Ignored
While unpleasant-smelling burps by themselves are generally very different from a serious gastrointestinal complication, medical advice should be sought where symptoms persist, worsen or occur alongside severe or continuous abdominal pain, repeated vomiting, a swollen or very tender abdomen, an inability to keep fluids down, signs of dehydration, blood or coffee-ground-like material in vomit, an inability to pass stools or wind, or pain spreading through to the back.
Emergency medical help is also required for signs of a serious allergic reaction, including swelling of the face, lips, tongue or throat, breathing difficulties, feeling faint or a rapidly spreading rash.
Sobia adds:
“The smell of a burp is not normally the most important detail. The concern is whether it appears alongside severe pain, repeated vomiting or an inability to drink.
Similarly, painful skin without a visible rash may not look alarming, but severe or persistent symptoms still warrant assessment.”
Why Regulated Prescribing Matters
The reports also underline why weight-management medicines should be obtained from regulated providers with appropriate clinical screening, dose escalation and ongoing monitoring.
Sobia concludes:
“Weight-loss injections can be effective for appropriate patients, but they remain prescription medicines with real side effects.
Medication bought through social media or an unregulated seller may not contain the advertised ingredient or strength. Without proper supervision, patients may also increase their dose too quickly or miss symptoms that require medical attention.
People should feel able to report the stranger symptoms as well as the commonly recognised ones. Details that seem embarrassing or unrelated may help a prescriber understand how the patient is responding to treatment.”
Methodology
Curely reviewed current UK product information for Wegovy alongside peer-reviewed case reports concerning allodynia and dysaesthesia associated with semaglutide and tirzepatide.
The 2.1% figure relates specifically to clinical trials involving Wegovy injections and should not be applied across every GLP-1 or weight-management medicine.
Evidence concerning tirzepatide and allodynia currently includes small case reports and case series. These reports can identify potential emerging reactions but cannot establish their frequency or prove causation.
Dietary information is intended as general guidance. Foods do not universally or chemically “react” with GLP-1 medicines, and individual tolerance varies.
Sources
- Wegovy UK Summary of Product Characteristics
- Allodynia (Skin Tenderness) Associated With Semaglutide: A Case Series, American Journal of Health-System Pharmacy, 2025
- Allodynia and Dysesthesia Associated With Semaglutide and Tirzepatide, Cureus, 2025
- Cutaneous Allodynia Associated With GLP-1RA Tirzepatide for Weight Management: A Case Series, American Journal of Case Reports, 2026
